Summary

Biological Imaging Reagents Market – Scope of Report
TMR’s report on the global biological imaging reagents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global biological imaging reagents market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global biological imaging reagents market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the biological imaging reagents market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global biological imaging reagents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global biological imaging reagents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global biological imaging reagents market.

The report delves into the competitive landscape of the global biological imaging reagents market. Key players operating in the global biological imaging reagents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global biological imaging reagents market profiled in this report.

Key Questions Answered in Global biological imaging reagents Market Report
• What is the sales/revenue generated by biological imaging reagents across all regions during the forecast period?
• What are the opportunities in the global biological imaging reagents market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Biological Imaging Reagents Market – Research Objectives and Research Approach
The comprehensive report on the global biological imaging reagents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global biological imaging reagents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global biological imaging reagents market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Biological Imaging Reagents Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Biological Imaging Reagents Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Biological Imaging Reagents Market Analysis and Forecast, by Class
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Class, 2017–2031
6.3.1. Contrast Agents
6.3.2. Optical Reagents
6.3.3. Nuclear Agents
6.4. Market Attractiveness, by Class
7. Global Biological Imaging Reagents Market Analysis and Forecast, by Modality
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Modality, 2017–2031
7.3.1. MRI
7.3.2. Ultrasound
7.3.3. X-Ray & CT
7.3.4. Nuclear
7.3.4.1. PET
7.3.4.2. SPECT
7.3.5. Optical Imaging
7.3.6. Others
7.3.7. 7.4 Market Attractiveness, by Modality
8. Global Biological Imaging Reagents Market Analysis and Forecast, By Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, By Application, 2017–2031
8.3.1. In Vitro
8.3.1.1. Proteomics
8.3.1.2. Genomics
8.3.1.3. Cell Biology
8.3.2. In Vivo
8.4. Market Attractiveness, By Application
9. Global Biological Imaging Reagents Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Diagnostic Laboratories
9.3.2. Life Science Companies
9.3.3. Imaging Centers
9.3.4. Academic & Research Institutes
9.3.5. Others
9.4. Market Attractiveness, by End-user
10. Global Biological Imaging Reagents Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Biological Imaging Reagents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Class, 2017–2031
11.2.1. Contrast Agents
11.2.2. Optical Reagents
11.2.3. Nuclear Agents
11.3. Market Attractiveness, by Class
11.4. Market Value Forecast, by Modality, 2017–2031
11.4.1. MRI
11.4.2. Ultrasound
11.4.3. X-Ray & CT
11.4.4. Nuclear
11.4.4.1. PET
11.4.4.2. SPECT
11.4.5. Optical Imaging
11.4.6. Others
11.5. Market Attractiveness, by Modality
11.6. Market Value Forecast, By Application, 2017–2031
11.6.1. In Vitro
11.6.1.1. Proteomics
11.6.1.2. Genomics
11.6.1.3. Cell Biology
11.6.2. In Vivo
11.7. Market Attractiveness, By Application
11.8. Market Value Forecast, by End-user, 2017–2031
11.8.1. Diagnostic Laboratories
11.8.2. Life Science Companies
11.8.3. Imaging Centers
11.8.4. Academic & Research Institutes
11.8.5. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Class
11.11.2. By Modality
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Biological Imaging Reagents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Class, 2017–2031
12.2.1. Contrast Agents
12.2.2. Optical Reagents
12.2.3. Nuclear Agents
12.3. Market Attractiveness, by Class
12.4. Market Value Forecast, by Modality, 2017–2031
12.4.1. MRI
12.4.2. Ultrasound
12.4.3. X-Ray & CT
12.4.4. Nuclear
12.4.4.1. PET
12.4.4.2. SPECT
12.4.5. Optical Imaging
12.4.6. Others
12.5. Market Attractiveness, by Modality
12.6. Market Value Forecast, By Application, 2017–2031
12.6.1. In Vitro
12.6.1.1. Proteomics
12.6.1.2. Genomics
12.6.1.3. Cell Biology
12.6.2. In Vivo
12.7. Market Attractiveness, By Application
12.8. Market Value Forecast, by End-user, 2017–2031
12.8.1. Diagnostic Laboratories
12.8.2. Life Science Companies
12.8.3. Imaging Centers
12.8.4. Academic & Research Institutes
12.8.5. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Class
12.11.2. By Modality
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Biological Imaging Reagents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Class, 2017–2031
13.2.1. Contrast Agents
13.2.2. Optical Reagents
13.2.3. Nuclear Agents
13.3. Market Attractiveness, by Class
13.4. Market Value Forecast, by Modality, 2017–2031
13.4.1. MRI
13.4.2. Ultrasound
13.4.3. X-Ray & CT
13.4.4. Nuclear
13.4.4.1. PET
13.4.4.2. SPECT
13.4.5. Optical Imaging
13.4.6. Others
13.5. Market Attractiveness, by Modality
13.6. Market Value Forecast, By Application, 2017–2031
13.6.1. In Vitro
13.6.1.1. Proteomics
13.6.1.2. Genomics
13.6.1.3. Cell Biology
13.6.2. In Vivo
13.7. Market Attractiveness, By Application
13.8. Market Value Forecast, by End-user, 2017–2031
13.8.1. Diagnostic Laboratories
13.8.2. Life Science Companies
13.8.3. Imaging Centers
13.8.4. Academic & Research Institutes
13.8.5. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Class
13.11.2. By Modality
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Biological Imaging Reagents Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Class, 2017–2031
14.2.1. Contrast Agents
14.2.2. Optical Reagents
14.2.3. Nuclear Agents
14.3. Market Attractiveness, by Class
14.4. Market Value Forecast, by Modality, 2017–2031
14.4.1. MRI
14.4.2. Ultrasound
14.4.3. X-Ray & CT
14.4.4. Nuclear
14.4.4.1. PET
14.4.4.2. SPECT
14.4.5. Optical Imaging
14.4.6. Others
14.5. Market Attractiveness, by Modality
14.6. Market Value Forecast, By Application, 2017–2031
14.6.1. In Vitro
14.6.1.1. Proteomics
14.6.1.2. Genomics
14.6.1.3. Cell Biology
14.6.2. In Vivo
14.7. Market Attractiveness, By Application
14.8. Market Value Forecast, by End-user, 2017–2031
14.8.1. Diagnostic Laboratories
14.8.2. Life Science Companies
14.8.3. Imaging Centers
14.8.4. Academic & Research Institutes
14.8.5. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Class
14.11.2. By Modality
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Biological Imaging Reagents Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Class, 2017–2031
15.2.1. Contrast Agents
15.2.2. Optical Reagents
15.2.3. Nuclear Agents
15.3. Market Attractiveness, by Class
15.4. Market Value Forecast, by Modality, 2017–2031
15.4.1. MRI
15.4.2. Ultrasound
15.4.3. X-Ray & CT
15.4.4. Nuclear
15.4.4.1. PET
15.4.4.2. SPECT
15.4.5. Optical Imaging
15.4.6. Others
15.5. Market Attractiveness, by Modality
15.6. Market Value Forecast, By Application, 2017–2031
15.6.1. In Vitro
15.6.1.1. Proteomics
15.6.1.2. Genomics
15.6.1.3. Cell Biology
15.6.2. In Vivo
15.7. Market Attractiveness, By Application
15.8. Market Value Forecast, by End-user, 2017–2031
15.8.1. Diagnostic Laboratories
15.8.2. Life Science Companies
15.8.3. Imaging Centers
15.8.4. Academic & Research Institutes
15.8.5. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Class
15.11.2. By Modality
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Bayer AG
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Thermo Fisher Scientific, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. PerkinElmer, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Guerbet
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Lantheus Holdings, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Bracco S.p.A.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. GE Healthcare
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Becton, Dickinson and Company (BD)
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Siemens Healthineers
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Luminex Corporation
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview